Speakers

Dr. Ben Swanson is a clinician-scientist and biotech entrepreneur focused on developing next-generation therapeutics for skeletal health. He is the founder and CEO of Skeletalis, Inc., a venture-backed biotechnology company advancing novel treatments for postmenopausal osteoporosis and related bone diseases, at the intersection of women's health and healthy aging. Trained as both a dentist and engineer, Ben brings deep translational expertise in bone biology, drug delivery, and patient care. His work bridges fundamental science and patient-centered innovation to transform outcomes in bone and women’s health. Skeletalis is based in the Lilly Gateway Labs in Boston.